DUODERM(R) CGF— 510(k) K881050

Substantially Equivalent for Some Indications

Convatec, A Division of E.R. Squibb & Sons

FDA 510(k) clearance K881050 for DUODERM(R) CGF, Substantially Equivalent for Some Indications on 1988-04-01. Applicant: Convatec, A Division of E.R. Squibb & Sons. Device class: 1.

Clearance details

Applicant
Convatec, A Division of E.R. Squibb & Sons
Product code
Code NAD
Device class
Class 1
Regulation
21 CFR 878.4020
Advisory panel
General, Plastic Surgery
Date received
Decision date
Decision
Substantially Equivalent for Some Indications
Clearance type
Traditional
Location
Princeton, NJ, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code NAD

view all

More clearances from Convatec, A Division of E.R. Squibb & Sons

view all

Adverse events under product code NAD

product code NAD
Injury
431
Malfunction
11,935
Other
1
Total
12,367

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.